NUZ 6.25% 22.5¢ neurizon therapeutics limited

PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-1305

  1. 12,310 Posts.
    lightbulb Created with Sketch. 6322
    Agree on PAA moving up swiftly when fully discovered by the investment community BUT @adreamer are you saying you wouldn't have wanted to be on RAC? PAA and RAC were at 9.5c simultaneously,,, Plus look out how engaging their CEO is.... delivering a message with out errrr,,ummmmm hmmmm..
    Discrediting other companies for participating on HC? to add a facade?
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.